HealthDay News — Subthalamic deep brain stimulation (DBS) is an effective long-term therapy for Parkinson disease (PD), according to a study published online September 15 in JAMA Neurology.

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.

The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has begun across the UK.

Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's ...

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoing Toronto, Ontario–(Newsfile Corp.

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...

One of the defining features of Parkinson’s is the presence of abnormal protein clumps in the brain known as Lewy bodies.

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...